| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
Apoptosis Laboratory, Institute of Cancer Biology, Danish Cancer Society, DK-2100 Copenhagen, Denmark
The hormonally active form of vitamin D3, 1,25-dihydroxyvitamin D3, and its two analogues, EB 1089 and CB 1093, are novel putative anticancer agents with an interesting profile of induction of growth inhibition, differentiation, and apoptosis in tumor cells. To study the signaling pathways mediating these events, we used two human breast cancer cell lines: MCF-7 cells, expressing a wild-type p53 tumor suppressor protein, and T47D cells, lacking a functional p53. Vitamin D compounds induced a growth arrest followed by apoptosis in both cell lines at concentrations ranging from 1 to 100 nM, indicating that p53 is not necessary for growth-inhibitory effects induced by vitamin D compounds. Surprisingly, apoptosis induced by these compounds occurred also independently of known caspases. Inhibition of caspase activation by overexpression of a cowpox-derived caspase inhibitor CrmA or by addition of inhibitory peptides acetyl-Asp-Glu-Val-Asp-aldehyde (200 µM), acetyl-Ile-Glu-Thr-Asp-aldehyde (50 µM), and Z-Val-Ala-D,L-Asp-fluoromethylketone (1 µM) showed no effect on the induction of growth arrest or apoptosis by vitamin D compounds under assay conditions in which apoptosis induced by TNF or staurosporine was effectively inhibited. Moreover, overexpression of caspase-3 in MCF-7 cells had no sensitizing effect to vitamin D compounds, and neither caspase-3-like protease activity nor cleavage of a caspase substrate poly(ADP)ribose polymerase was detected in lysates from apoptotic cells following the treatment with these compounds. Contrary to CrmA, overexpression of an antiapoptotic protein Bcl-2 in MCF-7 cells conferred a nearly complete protection from apoptosis induced by vitamin D compounds. Taken together, these data indicate that vitamin D compounds induce apoptosis via a novel caspase- and p53-independent pathway that can be inhibited by Bcl-2. This may prove useful in the treatment of tumors that are resistant to therapeutic agents that are dependent on the activation of p53 and/or caspases.
This article has been cited by other articles:
|
|
 |
|
  K. A. Bolanz, M. A. Hediger, and C. P. Landowski The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther., February 1, 2008; 7(2): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Broker, F. A.E. Kruyt, and G. Giaccone Cell Death Independent of Caspases: A Review Clin. Cancer Res., May 1, 2005; 11(9): 3155 - 3162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Crescioli, A. Morelli, L. Adorini, P. Ferruzzi, M. Luconi, G. B. Vannelli, M. Marini, S. Gelmini, B. Fibbi, S. Donati, et al. Human Bladder as a Novel Target for Vitamin D Receptor Ligands J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 962 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. Stewart and N. L. Weigel Vitamin D and Prostate Cancer Experimental Biology and Medicine, April 1, 2004; 229(4): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Beer and A. Myrthue Calcitriol in cancer treatment: From the lab to the clinic Mol. Cancer Ther., March 1, 2004; 3(3): 373 - 381. [Abstract] [Full Text]
|
|
|
|
 |
|
 U. Lademann, K. Cain, M. Gyrd-Hansen, D. Brown, D. Peters, and M. Jaattela Diarylurea Compounds Inhibit Caspase Activation by Preventing the Formation of the Active 700-Kilodalton Apoptosome Complex Mol. Cell. Biol., November 1, 2003; 23(21): 7829 - 7837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-Y. Ahn, G. Pan, J. H. Oh, E. M. Tytler, and J. M. McDonald The Combination of Calmodulin Antagonists and Interferon-{gamma} Induces Apoptosis through Caspase-Dependent and -Independent Pathways in Cholangiocarcinoma Cells Am. J. Pathol., November 1, 2003; 163(5): 2053 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Audo, S. R. Darjatmoko, C. L. Schlamp, J. M. Lokken, M. J. Lindstrom, D. M. Albert, and R. W. Nickells Vitamin D Analogues Increase p53, p21, and Apoptosis in a Xenograft Model of Human Retinoblastoma Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4192 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Brandi, M. Paiardini, B. Cervasi, C. Fiorucci, P. Filippone, C. De Marco, N. Zaffaroni, and M. Magnani A New Indole-3-Carbinol Tetrameric Derivative Inhibits Cyclin-dependent Kinase 6 Expression, and Induces G1 Cell Cycle Arrest in Both Estrogen-dependent and Estrogen-independent Breast Cancer Cell Lines Cancer Res., July 15, 2003; 63(14): 4028 - 4036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-L. Wong, A. Seow, K. Arakawa, H.-P. Lee, M. C. Yu, and S. A. Ingles Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese Carcinogenesis, June 1, 2003; 24(6): 1091 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Galbiati, L. Polastri, B. Thorens, P. Dupraz, P. Fiorina, U. Cavallaro, G. Christofori, and A. M. Davalli Molecular Pathways Involved in the Antineoplastic Effects of Calcitriol on Insulinoma Cells Endocrinology, May 1, 2003; 144(5): 1832 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Polek, L. V. Stewart, E. J. Ryu, M. B. Cohen, E. A. Allegretto, and N. L. Weigel p53 Is Required for 1,25-Dihydroxyvitamin D3-Induced G0 Arrest But Is Not Required for G1 Accumulation or Apoptosis of LNCaP Prostate Cancer Cells Endocrinology, January 1, 2003; 144(1): 50 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nylandsted, W. Wick, U. A. Hirt, K. Brand, M. Rohde, M. Leist, M. Weller, and M. Jaattela Eradication of Glioblastoma, and Breast and Colon Carcinoma Xenografts by Hsp70 Depletion Cancer Res., December 15, 2002; 62(24): 7139 - 7142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Drew, R. L. Fine, T. N. Do, G. P. Douglas, and D. P. Petrylak The Novel Antimicrotubule Agent Cryptophycin 52 (LY355703) Induces Apoptosis via Multiple Pathways in Human Prostate Cancer Cells Clin. Cancer Res., December 1, 2002; 8(12): 3922 - 3932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Foghsgaard, U. Lademann, D. Wissing, B. Poulsen, and M. Jaattela Cathepsin B Mediates Tumor Necrosis Factor-induced Arachidonic Acid Release in Tumor Cells J. Biol. Chem., October 11, 2002; 277(42): 39499 - 39506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Mathiasen, I. N. Sergeev, L. Bastholm, F. Elling, A. W. Norman, and M. Jaattela Calcium and Calpain as Key Mediators of Apoptosis-like Death Induced by Vitamin D Compounds in Breast Cancer Cells J. Biol. Chem., August 16, 2002; 277(34): 30738 - 30745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Kottke, A. L. Blajeski, X. W. Meng, P. A. Svingen, S. Ruchaud, P. W. Mesner Jr., S. A. Boerner, K. Samejima, N. V. Henriquez, T. J. Chilcote, et al. Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells J. Biol. Chem., January 4, 2002; 277(1): 804 - 815. [Abstract] [Full Text]
|
|
|
|
|
|
K. W. Crawford and W. D. Bowen Sigma-2 Receptor Agonists Activate a Novel Apoptotic Pathway and Potentiate Antineoplastic Drugs in Breast Tumor Cell Lines Cancer Res., January 1, 2002; 62(1): 313 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liang, K. D. Nylander, C. Yan, and N. F. Schor Role of Caspase 3-Dependent Bcl-2 Cleavage in Potentiation of Apoptosis by Bcl-2 Mol. Pharmacol., January 1, 2002; 61(1): 142 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Talapatra and C. B. Thompson Growth Factor Signaling in Cell Survival: Implications for Cancer Treatment J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 873 - 878. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Foghsgaard, D. Wissing, D. Mauch, U. Lademann, L. Bastholm, M. Boes, F. Elling, M. Leist, and M. Jaattela Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor J. Cell Biol., May 21, 2001; 153(5): 999 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-i. Hisatake, J. O'Kelly, M. R. Uskokovic, S. Tomoyasu, and H. P. Koeffler Novel vitamin D3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells Blood, April 15, 2001; 97(8): 2427 - 2433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. TORRIGLIA, P. PERANI, J. Y. BROSSAS, S. ALTAIRAC, S. ZEGGAI, E. MARTIN, J. TRETON, Y. COURTOIS, and M.-F. COUNIS A Caspase-Independent Cell Clearance Program: The LEI/L-DNase II Pathway Ann. N.Y. Acad. Sci., December 1, 2000; 926(1): 192 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bratland, K. Risberg, G. M. Mælandsmo, K. B. Gützkow, O. E. Olsen, A. Moghaddam, M.-y. Wang, C. M. Hansen, H. K. Blomhoff, J. P. Berg, et al. Expression of a Novel Factor, com1, Is Regulated by 1,25-Dihydroxyvitamin D3 in Breast Cancer Cells Cancer Res., October 1, 2000; 60(19): 5578 - 5583. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Nylandsted, M. Rohde, K. Brand, L. Bastholm, F. Elling, and M. Jaattela Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2 PNAS, July 5, 2000; 97(14): 7871 - 7876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Narvaez and J. Welsh Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells J. Biol. Chem., March 16, 2001; 276(12): 9101 - 9107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. McGuire, D. L. Trump, and C. S. Johnson Vitamin D3-induced Apoptosis of Murine Squamous Cell Carcinoma Cells. SELECTIVE INDUCTION OF CASPASE-DEPENDENT MEK CLEAVAGE AND UP-REGULATION OF MEKK-1 J. Biol. Chem., July 6, 2001; 276(28): 26365 - 26373. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
